Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,099 public trials 2,041 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Phase II Randomized Study With R-DHAP +/- Bortezomib as Induction Therapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Patients Eligible to Transplantation. BR-DHAP Versus R-DHAP.

NCT01805557

Conditions
Diffuse Large B-cell Lymphoma Recurrent, Diffuse Large B-cell Lymphoma Refractory, Hemic and Lymphatic Diseases, +10 more
Locations
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Ematologia Meldola, Forlì-Cesena, Italy
  • Clinica Humanitas Rozzano, Milano, Italy
  • ASST Grande Ospedale Metropolitano Niguarda - SC Ematologia Milan, MI, Italy
  • CRO Aviano Aviano, Pordenone, Italy
View all 24 locations
View Trial Details
Completed

Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze

NCT00634504

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hematologic Diseases, +19 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Good Samaritan Hospital Los Angeles, California, United States
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Los Angeles, California, United States
View all 25 locations
View Trial Details
Completed

Long-Term Follow-up Study for Patients Previously Treated With JCAR015

NCT02813252

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma

NCT01239797

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Northwest Alabama Cancer Center, Pc Muscle Shoals, Alabama, United States
  • Acrc/Arizona Clinical Research Center, Inc. Tucson, Arizona, United States
  • Local Institution Berkeley, California, United States
  • Local Institution Burbank, California, United States
View all 216 locations
View Trial Details
Completed

Daratumumab in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma and Severe Renal Impairment

NCT02977494

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Charité Universitätsmedizin BerlinCampus Benjamin Franklin Berlin, Germany
  • Vivantes Klinikum Neukölln Berlin, Germany
  • Klinikum Chemnitz GmbH Chemnitz, Germany
  • Katholische Karl-Leisner Klinikum Goch Goch, Germany
View Trial Details

Related conditions